Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-10-16
|
pubmed:abstractText |
Vasoactive intestinal peptide (VIP) can be found at nerve endings in various tissues and has recently been shown to interact with human lymphocytes through an adenylate cyclase-linked receptor. Because various neuroendocrine factors are thought to influence immune responsiveness, we studied the effect of VIP on natural killer (NK) effector function. Human lymphocytes were incubated with 51Cr-labeled K562 target cells in a 4-hr cytotoxicity assay in the absence or presence of increasing concentrations of VIP. As expected from its activation of adenylate cyclase, VIP was inhibitory at 10(-6) to 10(-10) M. Interestingly, however, when lymphocytes were preincubated with VIP for 30 or 60 min, then washed and added to target cells, a significant augmentation of NK activity ensued. Binding studies revealed that preincubation with VIP resulted in increased numbers of effector-target conjugates, whereas cytotoxic activity in agarose was not affected at the single cell level. Studies with synthetic analogs of VIP revealed that the integrity of the 14-28 C-terminal amino acid sequence was essential for its activity in cytotoxicity. These data strongly suggest a functional role for VIP in modulating immune responses during neuroendocrine interactions with the immune system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2569-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2993412-Cell Line,
pubmed-meshheading:2993412-Cyclic AMP,
pubmed-meshheading:2993412-Cytotoxicity, Immunologic,
pubmed-meshheading:2993412-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:2993412-Humans,
pubmed-meshheading:2993412-Immunosuppressive Agents,
pubmed-meshheading:2993412-Killer Cells, Natural,
pubmed-meshheading:2993412-Leukemia, Erythroblastic, Acute,
pubmed-meshheading:2993412-Structure-Activity Relationship,
pubmed-meshheading:2993412-Time Factors,
pubmed-meshheading:2993412-Vasoactive Intestinal Peptide
|
pubmed:year |
1985
|
pubmed:articleTitle |
The effects of vasoactive intestinal peptide on human natural killer cell function.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|